Table 3 of
Harman, Mol Vis 2018; 24:875-889. Table 3 of
Harman, Mol Vis 2018; 24:875-889.
Table 3. Summary report generated using IPA.
|
|
|
|
|---|---|---|
| EIF2 Signaling | 3.63E-33 | 67.6% (140/207) |
| Regulation of eIF4 and P70S6K Signaling | 2.06E-24 | 67.8% (101/149) |
| Mitochondrial Dysfunction | 1.58E-22 | 64.8% (103/159) |
| Huntington’s Disease Signaling | 2.07E-22 | 57.5% (138/240) |
| Sirtuin Signaling Pathway | 2.26E-21 | 55.0% (148/269) |
|
|
||
| 1. Metabolic Disease, Neurologic Disease, Organismal Injury and Abnormalities | ||
| 2. Cancer, Cell Death and Survival, Organismal Injury and Abnormalities | ||
| 3. Neurologic Disease, Ophthalmic Disease, Developmental Disorder | ||
| 4. Protein Synthesis, Gene Expression, Hereditary Disorder | ||
| 5. Cell-to-Cell Signaling and Interaction, Nervous System Development and Function, Neurologic Disease | ||